All Relations between Substantia nigra and dopamine

Publication Sentence Publish Date Extraction Date Species
Ricardo Pellón, Ana Ruíz, Margarita Moreno, Francisco Claro, Emilio Ambrosio, Pilar Flore. Individual differences in schedule-induced polydipsia: neuroanatomical dopamine divergences. Behavioural brain research. vol 217. issue 1. 2011-04-01. PMID:20974181. ld and hd rats showed opposite patterns of binding in dopamine d1 and d2 receptors in the nucleus accumbens, medial prefrontal cortex, amygdala, ventral tegmental area and substantia nigra. 2011-04-01 2023-08-12 rat
Nao Chuhma, Kenji F Tanaka, René Hen, Stephen Raypor. Functional connectome of the striatal medium spiny neuron. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 31. issue 4. 2011-03-30. PMID:21273403. in the substantia nigra, medium spiny neurons connected strongly with gaba, but not with dopamine neurons. 2011-03-30 2023-08-12 mouse
Nikolai Kholodilov, Sang Ryong Kim, Olga Yarygina, Tatyana Kareva, Jin Whan Cho, Amy Baohan, Robert E Burk. Glial cell line-derived neurotrophic factor receptor-α1 expressed in striatum in trans regulates development and injury response of dopamine neurons of the substantia nigra. Journal of neurochemistry. vol 116. issue 4. 2011-03-22. PMID:21133924. glial cell line-derived neurotrophic factor receptor-α1 expressed in striatum in trans regulates development and injury response of dopamine neurons of the substantia nigra. 2011-03-22 2023-08-12 mouse
G R Khakimova, E A Kozina, A Ya Sapronova, M V Ugryumo. Dopamine uptake in the substantia nigra and striatum in the presymptomatic and early symptomatic stages in parkinsonian mice. Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections. vol 435. 2011-03-17. PMID:21221887. dopamine uptake in the substantia nigra and striatum in the presymptomatic and early symptomatic stages in parkinsonian mice. 2011-03-17 2023-08-12 mouse
S Cechova, A M Elsobky, B J Vento. A1 receptors self-regulate adenosine release in the striatum: evidence of autoreceptor characteristics. Neuroscience. vol 171. issue 4. 2011-03-10. PMID:20933584. short electrical stimulation trains delivered to the substantia nigra (60 pulses, 60 hz) were used to evoke dopamine and adenosine release in the striatum. 2011-03-10 2023-08-12 Not clear
Hasna Erazi, Samir Ahboucha, Halima Gamran. Chronic exposure to aluminum reduces tyrosine hydroxylase expression in the substantia nigra and locomotor performance in rats. Neuroscience letters. vol 487. issue 1. 2011-03-09. PMID:20884324. the present study was designed to evaluate by means of immunohistochemistry using antibodies against tyrosine hydroxylase (th; the rate-limiting enzyme of dopamine synthesis) the effects of chronic al exposure (0, 3%) in drinking water during 4 months in adulthood or since intra-uterine age in the substantia nigra. 2011-03-09 2023-08-12 rat
S Gouty, J M Brown, J Rosenberger, B M Co. MPTP treatment increases expression of pre-pro-nociceptin/orphanin FQ mRNA in a subset of substantia nigra reticulata neurons. Neuroscience. vol 169. issue 1. 2011-03-04. PMID:20417255. we have evaluated the temporal relationship of dopamine cell loss to increased ppn/ofq mrna expression in the substantia nigra after mptp treatment, and characterized the cellular locations in which increased ppn/ofq mrna expression was observed after mptp treatment. 2011-03-04 2023-08-12 mouse
S Gouty, J M Brown, J Rosenberger, B M Co. MPTP treatment increases expression of pre-pro-nociceptin/orphanin FQ mRNA in a subset of substantia nigra reticulata neurons. Neuroscience. vol 169. issue 1. 2011-03-04. PMID:20417255. this period coincided with the timing of the loss of dopamine neurons from the pars compacta of substantia nigra (snc) after mptp. 2011-03-04 2023-08-12 mouse
Hernán Cortés, Francisco Paz, David Erlij, Jorge Aceves, Benjamín Florá. GABA(B) receptors modulate depolarization-stimulated [³H]glutamate release in slices of the pars reticulata of the rat substantia nigra. European journal of pharmacology. vol 649. issue 1-3. 2011-03-03. PMID:20863782. gaba(b) receptors decrease the release of gaba from the striatal terminals within the pars reticulata of the substantia nigra by opposing the increase in the release caused by dopamine d₁ receptors. 2011-03-03 2023-08-12 rat
Anamitra Ghosh, Karunakaran Chandran, Shasi V Kalivendi, Joy Joseph, William E Antholine, Cecilia J Hillard, Arthi Kanthasamy, Anumantha Kanthasamy, Balaraman Kalyanarama. Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model. Free radical biology & medicine. vol 49. issue 11. 2011-02-23. PMID:20828611. mptp treatment induced a loss of striatal dopamine and its metabolites, inactivation of mitochondrial aconitase in the substantia nigra, and a loss of locomotor activity in mice. 2011-02-23 2023-08-12 mouse
Kerstin E Braunstein, Judith Eschbach, Krisztina Ròna-Vörös, Rana Soylu, Elli Mikrouli, Yves Larmet, Frédérique René, Jose-Luis Gonzalez De Aguilar, Jean-Philippe Loeffler, Hans-Peter Müller, Selina Bucher, Thomas Kaulisch, Heiko G Niessen, Julia Tillmanns, Kristina Fischer, Birgit Schwalenstöcker, Jan Kassubek, Bernd Pichler, Detlef Stiller, Asa Petersen, Albert C Ludolph, Luc Dupui. A point mutation in the dynein heavy chain gene leads to striatal atrophy and compromises neurite outgrowth of striatal neurons. Human molecular genetics. vol 19. issue 22. 2011-02-17. PMID:20807776. in the striatum, altered dopamine signalling, decreased dopamine d1 and d2 receptor binding in positron emission tomography scan and prominent astrocytosis were observed, although there was no neuronal loss either in the striatum or substantia nigra. 2011-02-17 2023-08-12 mouse
Yeong-Gon Choi, Sabina Li. N(ɛ)-(carboxymethyl)lysine linkage to α-synuclein and involvement of advanced glycation end products in α-synuclein deposits in an MPTP-intoxicated mouse model. Biochimie. vol 92. issue 10. 2011-02-16. PMID:20624443. results show that the immunoreactivities of the tyrosine hydroxylase and dopamine transporter significantly decreased in the striatum and the substantia nigra (sn) in the mptp model compared to the subjects in the control group. 2011-02-16 2023-08-12 mouse
Antonio Bueno-Nava, Rigoberto Gonzalez-Pina, Alfonso Alfaro-Rodrigue. Iron-dextran injection into the substantia nigra in rats decreases striatal dopamine content ipsilateral to the injury site and impairs motor function. Metabolic brain disease. vol 25. issue 2. 2011-01-13. PMID:20424901. iron-dextran injection into the substantia nigra in rats decreases striatal dopamine content ipsilateral to the injury site and impairs motor function. 2011-01-13 2023-08-12 rat
Keiko Nakamura, Kyoko Itoh, Kanji Yoshimoto, Tohru Sugimoto, Shinji Fushik. Prenatal and lactational exposure to low-doses of bisphenol A alters brain monoamine concentration in adult mice. Neuroscience letters. vol 484. issue 1. 2010-12-28. PMID:20709143. the levels of dopamine and its metabolite significantly increased in the caudate/putamen and dorsal raphe nucleus, whereas serotonin and its metabolite increased in the caudate/putamen, dorsal raphe nucleus, thalamus and substantia nigra in the bpa-exposure group at both p3w and/or p14-15w. 2010-12-28 2023-08-12 mouse
Andre Chevrier, Russell J Schacha. Error detection in the stop signal task. NeuroImage. vol 53. issue 2. 2010-12-16. PMID:20600968. error detection deactivated the midbrain in the vicinity of dorsal substantia nigra where dopamine neurons originate, and the primary targets of dopamine neurons: dorsal striatum and ventral anterior cingulate. 2010-12-16 2023-08-12 human
Matteo Marti, Silvio Sarubbo, Francesco Latini, Michele Cavallo, Roberto Eleopra, Sara Biguzzi, Christian Lettieri, Carlo Conti, Michele Simonato, Silvia Zucchini, Rocco Quatrale, Mariachiara Sensi, Sanzio Candeletti, Patrizia Romualdi, Michele Morar. Brain interstitial nociceptin/orphanin FQ levels are elevated in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. vol 25. issue 11. 2010-12-10. PMID:20589874. in situ hybridization demonstrated that dopamine depletion was associated with increase of n/ofq expression in substantia nigra (compacta +160%, reticulata +105%) and subthalamic nucleus (+45%), as well as reduction in caudate putamen (-20%). 2010-12-10 2023-08-12 rat
Brandon S Pruett, Michael F Salvator. GFR α-1 receptor expression in the aging nigrostriatal and mesoaccumbens pathways. Journal of neurochemistry. vol 115. issue 3. 2010-12-02. PMID:20731758. we recently reported that age-related bradykinesia was associated with reduced dopamine (da) tissue content, ser31 tyrosine hydroxylase (th) phosphorylation, and total th levels in substantia nigra (sn) only. 2010-12-02 2023-08-12 rat
Ethan S Bromberg-Martin, Masayuki Matsumoto, Simon Hong, Okihide Hikosak. A pallidus-habenula-dopamine pathway signals inferred stimulus values. Journal of neurophysiology. vol 104. issue 2. 2010-12-01. PMID:20538770. we then recorded from three populations of reward-coding neurons: substantia nigra dopamine neurons; a major input to dopamine neurons, the lateral habenula; and neurons that project to the lateral habenula, located in the globus pallidus. 2010-12-01 2023-08-12 monkey
Li Qian, Patrick M Flood, Jau-Shyong Hon. Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy. Journal of neural transmission (Vienna, Austria : 1996). vol 117. issue 8. 2010-11-30. PMID:20571837. parkinson's disease (pd) is a neurodegenerative movement disorder characterized by the progressive loss of dopaminergic neurons in the substantia nigra and depletion of dopamine in the striatum, which lead to pathological and clinical abnormalities. 2010-11-30 2023-08-12 Not clear
Alex Iranzo, Francisco Lomeña, Heike Stockner, Francesc Valldeoriola, Isabel Vilaseca, Manel Salamero, Jose Luis Molinuevo, Monica Serradell, Joan Duch, Javier Pavía, Judith Gallego, Klaus Seppi, Birgit Högl, Eduard Tolosa, Werner Poewe, Joan Santamari. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected]. The Lancet. Neurology. vol 9. issue 11. 2010-11-16. PMID:20846908. decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected]. 2010-11-16 2023-08-12 Not clear